Open AccessAbstract CT237: A phase I study to assess the safety, tolerability, and immunogenicity of personalized neoantigen/cancer testis antigen nanovaccine (PVAC) for high-risk resected gastric cancer
Author(s) -
Qin Liu,
Qian Hu,
Jie Shao,
Qiuping Xu,
Huizi Sha,
Yang Yang,
Weifeng Wang,
Lan Yu,
Baorui Liu,
Jia Wei
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct237
Subject(s) - medicine , cancer , antigen , immunogenicity , adjuvant , cancer research , oncology , immunology